CDH5
Cadherin-5
Also known as: 7B4, CADH5_HUMAN, CD144
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P33151
- Gene
- CDH5
- Ensembl
- ENSG00000179776
- Chromosome
- 16
- Canonical length
- 784 aa
- Protein class
- Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Nuclear membrane,Plasma membrane
OverviewNCBI Gene
This gene encodes a classical cadherin of the cadherin superfamily. The encoded preproprotein is proteolytically processed to generate the mature glycoprotein. This calcium-dependent cell-cell adhesion molecule is comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Functioning as a classical cadherin by imparting to cells the ability to adhere in a homophilic manner, this protein plays a role in endothelial adherens junction assembly and maintenance. This gene is located in a gene cluster in a region on the long arm of chromosome 16 that is involved in loss of heterozygosity events in breast and prostate cancer. [provided by RefSeq, Nov 2015]
Canonical amino-acid sequenceUniProt
784 residues, UniProt reviewed canonical sequence.
>P33151|CDH5
1 MQRLMMLLAT SGACLGLLAV AAVAAAGANP AQRDTHSLLP THRRQKRDWI WNQMHIDEEK
61 NTSLPHHVGK IKSSVSRKNA KYLLKGEYVG KVFRVDAETG DVFAIERLDR ENISEYHLTA
121 VIVDKDTGEN LETPSSFTIK VHDVNDNWPV FTHRLFNASV PESSAVGTSV ISVTAVDADD
181 PTVGDHASVM YQILKGKEYF AIDNSGRIIT ITKSLDREKQ ARYEIVVEAR DAQGLRGDSG
241 TATVLVTLQD INDNFPFFTQ TKYTFVVPED TRVGTSVGSL FVEDPDEPQN RMTKYSILRG
301 DYQDAFTIET NPAHNEGIIK PMKPLDYEYI QQYSFIVEAT DPTIDLRYMS PPAGNRAQVI
361 INITDVDEPP IFQQPFYHFQ LKENQKKPLI GTVLAMDPDA ARHSIGYSIR RTSDKGQFFR
421 VTKKGDIYNE KELDREVYPW YNLTVEAKEL DSTGTPTGKE SIVQVHIEVL DENDNAPEFA
481 KPYQPKVCEN AVHGQLVLQI SAIDKDITPR NVKFKFILNT ENNFTLTDNH DNTANITVKY
541 GQFDREHTKV HFLPVVISDN GMPSRTGTST LTVAVCKCNE QGEFTFCEDM AAQVGVSIQA
601 VVAILLCILT ITVITLLIFL RRRLRKQARA HGKSVPEIHE QLVTYDEEGG GEMDTTSYDV
661 SVLNSVRRGG AKPPRPALDA RPSLYAQVQK PPRHAPGAHG GPGEMAAMIE VKKDEADHDG
721 DGPPYDTLHI YGYEGSESIA ESLSSLGTDS SDSDVDYDFL NDWGPRFKML AELYGSDPRE
781 ELLYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CDH5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 222 nTPM
Expression across tissuesHPA
Tissue
- placenta: 222 nTPM
- lung: 91 nTPM
- heart muscle: 84 nTPM
- adipose tissue: 81 nTPM
- breast: 70 nTPM
- tongue: 55 nTPM
Single-cell type
- vascular endothelial cells: 244 nCPM
- lymphatic endothelial cells: 168 nCPM
- late spermatids: 143 nCPM
- syncytiotrophoblasts: 126 nCPM
- kupffer cells: 102 nCPM
- extravillous trophoblasts: 69 nCPM
Immune cell
- total PBMC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- thalamus: 36 nTPM
- pons: 25 nTPM
- medulla oblongata: 22 nTPM
- midbrain: 22 nTPM
- amygdala: 21 nTPM
- cerebral cortex: 21 nTPM
ReferencesPubMed · IEDB
Publications for CDH5 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Auto-antibodies to vascular endothelial cadherin in humans: association with autoimmune diseases.
2013 · Lab Invest · RCR 0.6 · 18 citations - Soluble vascular endothelial (VE) cadherin and autoantibodies to VE-cadherin in rheumatoid arthritis patients treated with etanercept or adalimumab.
2017 · Joint Bone Spine · RCR 0.2 · 5 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.4
- gnomAD pLI
- 0.51
- gnomAD missense Z
- 0.52
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adherens junction organization
- bicellular tight junction assembly
- blood vessel endothelial cell migration
- blood vessel maturation
- calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules
- cell migration
- cell migration involved in sprouting angiogenesis
- cell morphogenesis
- cell surface receptor signaling pathway
- cell-cell adhesion
- cell-cell adhesion mediated by cadherin
- cell-cell junction assembly
- endothelial cell morphogenesis
- homophilic cell adhesion via plasma membrane adhesion molecules
- intracellular calcium ion homeostasis
- maintenance of blood-brain barrier
- negative regulation of cell population proliferation
- negative regulation of endothelial cell apoptotic process
- negative regulation of inflammatory response
- negative regulation of microtubule polymerization
- positive regulation of angiogenesis
- positive regulation of BMP signaling pathway
- positive regulation of cell migration
- positive regulation of establishment of endothelial barrier
- positive regulation of gene expression
- positive regulation of intracellular signal transduction
- positive regulation of protein-containing complex assembly
- protein localization to bicellular tight junction
- regulation of establishment of cell polarity
- regulation of vascular permeability
- transforming growth factor beta receptor signaling pathway
Molecular functions
- beta-catenin binding
- BMP receptor binding
- cadherin binding
- calcium ion binding
- cell-cell adhesion mediator activity
- fibrinogen binding
- protein phosphatase binding
- protein tyrosine kinase binding
- signaling receptor binding
- signaling receptor complex adaptor activity
- transmembrane transporter binding
- vascular endothelial growth factor receptor 2 binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CDH5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CDH5 as an antibody target. Whether an autoantibody or antibody against CDH5 could matter depends on whether native CDH5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CDH5 is annotated at the cell surface, where native CDH5 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CDH5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...